Ben R Taylor Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity

Ben R Taylor is Chief Financial Officer of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 761,550 shares of RXRX, which is worth approximately $3.15 Million. The most recent transaction as insider was on Dec 29, 2025, when has been sold 21,383 shares (Class A Common Stock) at a price of $4.18 per share, resulting in proceeds of $89,380. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 762K

5.3% 3M change

9.79% 12M change

Total Value Held $3.15 Million

Ben R Taylor Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 29 2025	SELL Open market or private sale	$89,380 $4.18 p/Share	21,383 Reduced 2.73%	761,550 Class A Common Stock
Dec 15 2025	SELL Payment of exercise price or tax liability	$30,556 $4.33 p/Share	7,057 Reduced 0.89%	782,933 Class A Common Stock
Nov 25 2025	SELL Payment of exercise price or tax liability	$9,152 $4.03 p/Share	2,271 Reduced 0.29%	789,990 Class A Common Stock
Nov 17 2025	SELL Payment of exercise price or tax liability	$49,299 $4.14 p/Share	11,908 Reduced 1.48%	792,261 Class A Common Stock
Sep 15 2025	SELL Payment of exercise price or tax liability	$34,085 $4.83 p/Share	7,057 Reduced 0.87%	804,169 Class A Common Stock
Aug 15 2025	SELL Payment of exercise price or tax liability	$67,161 $5.64 p/Share	11,908 Reduced 1.45%	811,226 Class A Common Stock
Jun 16 2025	SELL Payment of exercise price or tax liability	$34,720 $4.92 p/Share	7,057 Reduced 0.85%	823,134 Class A Common Stock

May 15 2025	SELL Payment of exercise price or tax liability	$50,609 $4.25 p/Share	11,908 Reduced 1.41%	830,191 Class A Common Stock
Apr 01 2025	SELL Payment of exercise price or tax liability	$135,246 $5.09 p/Share	26,571 Reduced 3.06%	842,099 Class A Common Stock
Mar 17 2025	SELL Payment of exercise price or tax liability	$48,269 $6.84 p/Share	7,057 Reduced 0.81%	868,670 Class A Common Stock
Feb 18 2025	SELL Payment of exercise price or tax liability	$115,752 $10.64 p/Share	10,879 Reduced 1.23%	875,727 Class A Common Stock
Feb 03 2025	SELL Payment of exercise price or tax liability	$47,444 $7.25 p/Share	6,544 Reduced 0.73%	886,606 Class A Common Stock
Feb 03 2025	BUY Grant, award, or other acquisition	-	48,940 Added 5.19%	893,150 Class A Common Stock
Dec 19 2024	BUY Grant, award, or other acquisition	-	370,343 Added 30.49%	844,210 Class A Common Stock
Dec 17 2024	SELL Payment of exercise price or tax liability	$49,046 $6.95 p/Share	7,057 Reduced 1.47%	473,867 Class A Common Stock
Dec 16 2024	SELL Payment of exercise price or tax liability	$94,634 $6.04 p/Share	15,668 Reduced 3.16%	480,924 Class A Common Stock

BRT

Ben R Taylor

Chief Financial Officer

Salt Lake City, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Value

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Track Activities on RXRX

Account